MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BBOT has $484,793K in assets. $38,093K in debts. $408,741K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1332.91%
Cash Ratio
1144.55%
Debt to Asset Ratio
7.86%
Assets Breakdown
    • Cash and cash equivalents
    • Short-term marketable securities
    • Prepaid expense and other curren...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued research and development...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
Cash and cash equivalents
408,741
Short-term marketable securities
59,544
Receivables from related parties
226
Prepaid expense and other current assets
7,499
Total current assets
476,010
Property and equipment, net
827
Operating lease right-of-use asset
2,440
Other non-current assets
5,384
Restricted cash
132
Total assets
484,793
Accounts payable
3,650
Accrued compensation and benefits
4,489
Accrued research and development liabilities
24,107
Accrued professional services
2,091
Payables to related parties
691
Operating lease liability, current
506
Other accrued liabilities
178
Participation right liability
0
Total current liabilities
35,712
Operating lease liability, noncurrent
2,381
Total liabilities
38,093
Preference stock, value-Redeemable Convertible Preferred Stock
0
Preference stock, value-Preferred Stock
0
Common stock, 0.0001 par value 500,000,000 and 41,341,250 shares authorized as of september 30, 2025 and december 31, 2024, respectively 79,196,710 and 28,415 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
8
Additional paid-in capital
764,426
Accumulated deficit
-317,770
Accumulated other comprehensive income
36
Total stockholders' equity (deficit)
446,700
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)
484,793
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expense andother current assets$7,499K Receivables from relatedparties$226K Short-term marketablesecurities$59,544K Cash and cashequivalents$408,741K Restricted cash$132K Other non-currentassets$5,384K Operating leaseright-of-use asset$2,440K Property and equipment,net$827K Total current assets$476,010K Total assets$484,793K Total liabilities,redeemable convertible...$484,793K Total stockholders'equity (deficit)$446,700K Total liabilities$38,093K Accumulated deficit-$317,770K Accumulated othercomprehensive income$36K Additional paid-in capital$764,426K Operating leaseliability, noncurrent$2,381K Total currentliabilities$35,712K Common stock, 0.0001par value...$8K Other accruedliabilities$178K Operating leaseliability, current$506K Payables to relatedparties$691K Accrued professionalservices$2,091K Accrued research anddevelopment liabilities$24,107K Accrued compensationand benefits$4,489K Accounts payable$3,650K

BridgeBio Oncology Therapeutics, Inc. (BBOT)

BridgeBio Oncology Therapeutics, Inc. (BBOT)